Sebelipase Alfa Strength Indicated Is For Final Drug Product And Is Not Administered To The Animal.
16 adverse event reports submitted to the FDA
Important: Adverse event reports do not establish that a drug caused or contributed to the event. Consult your veterinarian before making treatment decisions.
16
Total Reports
16
Deaths Reported
10000.0%
Death Rate
Active Ingredients
Sebelipase Alfa Strength Indicated Is For Final Drug Product And Is Not Administered To The Animal.
Administration Routes
Unknown
Species Affected
Chicken 15
Chinchilla 1
Most Affected Breeds
Unknown 16
Most Reported Reactions
IGA Animal mortality greater than expected 16
IGA Animal morbidity greater than expected 15
Found dead 3
Death 1
Outcome Breakdown
Euthanized
16 (55.2%)
Died
13 (44.8%)
Source: FDA Center for Veterinary Medicine — Adverse Event Reports. Data reflects voluntary submissions and may not represent actual incidence rates.